⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Sina NajafiD.O.

Internal Medicine · Dallas, TX 75246

NPI: 1780048637

Share:

38

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

556

Total Claims

$44K

Drug Cost

90

Beneficiaries

$494

Cost/Patient

Risk Score Breakdown 38/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+1981%

Opioid rate vs peers

46.6% vs 2.2% avg

-65%

Cost per patient vs peers

$494 vs $1,411 avg

+20%

Brand preference vs peers

12.8% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 1,981% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

46.6%

Opioid Rate

259

Opioid Claims

$30K

Opioid Cost

32.4%

Long-Acting Rate

This provider's opioid prescribing rate of 46.6% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

87% generic

Brand: 71 claims · $26K

Generic: 485 claims · $19K

Patient Profile

66

Avg Age

58%

Female

4.38

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About